All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
| QUOT / Quotient Technology Inc
|
|
|
|
|
|
|
|
| FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
| FGEN / FibroGen, Inc.
|
|
|
|
|
|
|
|
| INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
| BOLD / Boundless Bio, Inc.
|
|
|
|
|
|
|
|
| NDRM / NeuroDerm Ltd.
|
|
|
|
|
|
|
|
| ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| US60877T1007 / Momenta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| LOXO / Loxo Oncology, Inc.
|
|
|
|
|
|
|
|
| / Immunomedics, Inc.
|
|
|
|
|
|
|
|
| BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
| PETX / Aratana Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SBBP / Strongbridge Biopharma plc
|
|
|
|
|
|
|
|
| WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
| US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ZSAN / Zosano Pharma Corp
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
| 74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
|
|
|
|
|
|
|
|
| INTRA CELLULAR THERAPIES INC
/ (04611X101) |
|
|
|
|
|
|
|
| US64052L1061 / Neos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NVLN / NOVELION THERAPEUTICS INC.
|
|
|
|
|
|
|
|
| ICPT / Intercept Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| CMRX / Chimerix, Inc.
|
|
|
|
|
|
|
|
| AXGN / Axogen, Inc.
|
|
|
|
|
|
|
|
| CORI / Corium International, Inc.
|
|
|
|
|
|
|
|
| RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ARQL / ArQule, Inc.
|
|
|
|
|
|
|
|
| DCPH / Deciphera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SELB / Selecta Biosciences Inc
|
|
|
|
|
|
|
|
| TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
|
|
|
|
|
| XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
| PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|
| VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ADMS / Adamas Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| SYBX / Synlogic, Inc.
|
|
|
|
|
|
|
|
| PDSB / PDS Biotechnology Corporation
|
|
|
|
|
|
|
|
| ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
| BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| EGRX / Eagle Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CBAY / CymaBay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TBPH / Theravance Biopharma, Inc.
|
|
|
|
|
|
|
|
| XOMA / XOMA Royalty Corporation
|
|
|
|
|
|
|
|
| HROW / Harrow, Inc.
|
|
|
|
|
|
|
|
| CDXS / Codexis, Inc.
|
|
|
|
|
|
|
|
